InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics.
InMode Ltd (INMD) CEO Moshe Mizrahy on Q1 2021 Results - Earnings Call Transcript

A Trio of Strong Performers to Consider

11:21am, Wednesday, 05'th May 2021
Shareholders of Builders FirstSource Inc (BLDR, Financial), Deckers Outdoor Corp (DECK, Financial) and InMode Ltd (INMD, Financial) saw the value of their assets increase significantly in recent years
YOKNEAM, Israel, May 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its
InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have continued to contribute to the company's Q1 top line.
YOKNEAM, Israel, April 12, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial resu
YOKNEAM, Israel, March 30, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced Mr.
Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.
MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.
Founder-owners have demonstrated a strong track record of growth and profitability. The company's pristine balance sheet affords new pathways for growth and share repurchases.
InMode (INMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength dow
InMode's (INMD) CEO Moshe Mizrahy on Q4 2020 Results - Earnings Call Transcript

Recap: InMode Q4 Earnings

07:31am, Wednesday, 10'th Feb 2021
Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 104.35% over the past year to $0.94, which beat the
YOKNEAM, Israel, Feb. 10, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for i
InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have contributed to the company's Q4 top line.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE